[ sulge aken ]
| Elulookirjeldus (CV) | ||
| 1. | Eesnimi | Andres |
| 2. | Perekonnanimi | Kulla |
| 3. | Töökoht | SA TÜ Kliinikum |
| 4. | Ametikoht | Patoloogiateenistuse direktor |
| 5. | Sünniaeg | 08.04.1966 (päev.kuu.aasta) |
| 6. | Haridus | 1973-1984 Tartu 10.Keskkool 1984-992 Tartu Ülikooli arstiteaduskonna ravi osakond |
| 7. | Teenistuskäik | 1992-1993 Tartu Maarjamõisa Haigla, intern 1993-1995 Tallinna Mustamäe Haigla ja Tartu Maarjamõisa Haigla patoloogiaosakonnad, patoloogia resident 1996-1999 Tartu Maarjamõisa Haigla, patoloogiaosakonna juhataja 1999- Tartu Ülikooli Kliinikum, patoloogiateenistuse direktor |
| 8. | Teaduskraad | Ph.D |
| 9. | Teaduskraadi välja andnud asutus, aasta |
Tartu Ülikool, 2004 |
| 10. | Tunnustused | |
| 11. | Teadusorganisatsiooniline ja –administratiivne tegevus |
|
| 12. | Juhendamisel kaitstud väitekirjad |
|
| 13. | Teadustöö põhisuunad | Peamiseks uurimisvaldkonnaks on rakuvälise maatriksi osatähtsus inimese glioomide malignisatsioonis ja invasiivses käitumises. |
| 14. | Jooksvad grandid | |
| 15. | Teaduspublikatsioonid |
Teesalu T, Kulla A, Simisker A, Sirėn, Lawrence D, Asser T, Vaheri A. Tissue plasminogen activator and neuroserpin are widely expressed in human central nervous system. Thromb Haemost, 2004, 92:358-68, Medline, PubMed Kulla A, Burckhardt K, Meyer-Puttlitz B, Teesalu T, Asser T, Wiestler O, Becker AJ. Analysis of the p53 gene in laser-microdissected glioblastoma vasculature. Acta Neuropathol 2003, 105:328-332 , Medline, PubMed Teesalu T, Kulla A, Asser T, Simisker A, Vaheri A. Plasminogen Activators in CNS Physiology and Disease. In: Waisman D (Ed). Plasminogen: Structure, Activation, and Regulation. Kluwer Academic/Plenum Publishers, New York, Boston, Dordrecht, London, Moscow, 2003 pp:251-267 Kulla A, Teesalu T Simisker A, Asser T. Molecular mechanisms of invasion of astrocytic tumours. Review. In: Neuropathology – back to the roots. Festschrift for Prof. Dr. H.H. Goebel at the association of his 65th anniversary May 2002. Ed: Bohl J. Shaker Verlag, Aachen Teesalu T, Kulla A, Asser, T, Koskiniemi M, Vaheri A. Tissue plasminogen activator as a key factor in neurobiology and neuropathology. Biochem Soc Trans 2002, 30: 183-189, Medline, PubMed Liigant A, Kulla A, Linnamagi U, Asser T, Kaasik AE. Survival of patients with primary CNS tumours in Estonia. Eur J Cancer 2001, 37:1895-903, Medline, PubMed Kulla A, Liigant A, Piirsoo A, Rippin G, Asser T. Tenascin expression and cells of monocyte lineage: relationship in human gliomas. Mod Pathol. 2000,13:56-67. Medline, PubMed Liigant A, Kulla A, Asser T, Kaasik A-E. Epidemiology of Primary Central Nervous System Tumors in Estonia. Neuroepidemiology, 2000,19:300-311, Medline, PubMed |
viimati muudetud: 12.08.2005
| Curriculum Vitae (CV) | ||
| 1. | First Name | Andres |
| 2. | Surname | Kulla |
| 3. | Institution | Tartu University Clinics |
| 4. | Position | Director of the Dept. of Pathology |
| 5. | Date of birth | 08.04.1966 (day.month.year) |
| 6. | Education | 1973-1984 Tartu Secondary School No 10 1984-1992 University of Tartu, Faculty of Medicine |
| 7. | Research and professional experience |
1992-1993 Tartu Maarjamõisa Hospital, internship 1993-1995 Departments of Pathology of Tallinn Mustamäe Hospital and Tartu Maarjamõisa Hospital, training in clinical pathology 1996-1999 Tartu Maarjamõisa Hospital, head of Department of Pathology 1999- Tartu University Clinics, Director of Department of Pathology and Neuropathology |
| 8. | Academic degree | Ph.D |
| 9. | Dates and sites of earning the degrees |
Tartu University, 2004 |
| 10. | Honours/awards | |
| 11. | Research-administrative experience |
|
| 12. | Supervised dissertations | |
| 13. | Current research program | Main scientific research focuses upon investigation of role of extracellular matrix proteins and stromal remodeling in malignant progression and invasive behaviour of human gliomas. |
| 14. | Current grant funding | |
| 15. | List of most important publications |
Teesalu T, Kulla A, Simisker A, Sirėn, Lawrence D, Asser T, Vaheri A. Tissue plasminogen activator and neuroserpin are widely expressed in human central nervous system. Thromb Haemost, 2004, 92:358-68, Medline, PubMed Kulla A, Burckhardt K, Meyer-Puttlitz B, Teesalu T, Asser T, Wiestler O, Becker AJ. Analysis of the p53 gene in laser-microdissected glioblastoma vasculature. Acta Neuropathol 2003, 105:328-332 , Medline, PubMed Teesalu T, Kulla A, Asser T, Simisker A, Vaheri A. Plasminogen Activators in CNS Physiology and Disease. In: Waisman D (Ed). Plasminogen: Structure, Activation, and Regulation. Kluwer Academic/Plenum Publishers, New York, Boston, Dordrecht, London, Moscow, 2003 pp:251-267 Kulla A, Teesalu T Simisker A, Asser T. Molecular mechanisms of invasion of astrocytic tumours. Review. In: Neuropathology – back to the roots. Festschrift for Prof. Dr. H.H. Goebel at the association of his 65th anniversary May 2002. Ed: Bohl J. Shaker Verlag, Aachen Teesalu T, Kulla A, Asser, T, Koskiniemi M, Vaheri A. Tissue plasminogen activator as a key factor in neurobiology and neuropathology. Biochem Soc Trans 2002, 30: 183-189, Medline, PubMed Liigant A, Kulla A, Linnamagi U, Asser T, Kaasik AE. Survival of patients with primary CNS tumours in Estonia. Eur J Cancer 2001, 37:1895-903, Medline, PubMed Kulla A, Liigant A, Piirsoo A, Rippin G, Asser T. Tenascin expression and cells of monocyte lineage: relationship in human gliomas. Mod Pathol. 2000,13:56-67. Medline, PubMed Liigant A, Kulla A, Asser T, Kaasik A-E. Epidemiology of Primary Central Nervous System Tumors in Estonia. Neuroepidemiology, 2000,19:300-311, Medline, PubMed |
last updated: 12.08.2005
[ sulge aken ]